2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone has been researched along with Papilloma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolan, PM; Guyton, KZ; Kensler, TW | 1 |
| Kensler, TW; Taffe, BG | 1 |
2 other study(ies) available for 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone and Papilloma, Squamous Cell
| Article | Year |
|---|---|
Quinone methide mediates in vitro induction of ornithine decarboxylase by the tumor promoter butylated hydroxytoluene hydroperoxide.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Base Sequence; Butylated Hydroxytoluene; Carcinogens; Cells, Cultured; Chelating Agents; Drug Synergism; Enzyme Induction; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Indolequinones; Indoles; Isoquinolines; Keratinocytes; Mice; Molecular Sequence Data; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Papilloma; Peroxides; Piperazines; Protein Kinase C; Quinones; Skin Neoplasms; Structure-Activity Relationship; Sulfhydryl Compounds | 1994 |
Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Butylated Hydroxytoluene; Carcinogens; Cocarcinogenesis; Dose-Response Relationship, Drug; Female; Mice; Ornithine Decarboxylase; Papilloma; Peroxides; Quinones; Skin; Skin Neoplasms | 1988 |